Cargando…

Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma

Despite recent advances in targeted therapies and immunotherapies metastatic melanoma remains only rarely curable. The objective of the present study was to identify novel therapeutic targets for metastatic melanoma. A library of 160 well-characterised and potent protein kinase inhibitors was screen...

Descripción completa

Detalles Bibliográficos
Autores principales: MAHGOUB, T., EUSTACE, A.J., COLLINS, D.M., WALSH, N., O'DONOVAN, N., CROWN, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532220/
https://www.ncbi.nlm.nih.gov/pubmed/26201960
http://dx.doi.org/10.3892/ijo.2015.3097